Dr Tonya Blache, MD | |
1117 Chilmark Ave, Wake Forest, NC 27587-5334 | |
(919) 569-6708 | |
Not Available |
Full Name | Dr Tonya Blache |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
Location | 1117 Chilmark Ave, Wake Forest, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629445325 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 35057 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Tonya Blache, MD 1117 Chilmark Ave, Wake Forest, NC 27587-5334 Ph: (919) 569-6708 | Dr Tonya Blache, MD 1117 Chilmark Ave, Wake Forest, NC 27587-5334 Ph: (919) 569-6708 |
News Archive
Los Angeles Biomedical Research Institute's physician-researchers continue to rate among the nation's and the region's best doctors, with 44 of them listed among Southern California Super Doctors for 2015 or set to be listed among America's Top Doctors when it issues its 2015 publication later this year.
Kronos Longevity Research Institute (KLRI) has announced plans for the Kronos Early Estrogen Prevention Study (KEEPS), a five-year study of female hormone replacement therapy aimed at providing prospective data on the risks and benefits of early menopausal hormonal intervention, particularly as it relates to the progression of atherosclerosis. Atherosclerosis is a medical condition in which fatty material is deposited along the walls of arteries.
Bruin Biometrics, LLC has been granted U.S. Food and Drug Administration marketing authorization for the SEM Scanner, becoming the world's first FDA-authorised device to objectively alert clinicians to specific anatomical areas of a patient's body at increased risk for developing pressure damage.
Back in spring 2009, the H1N1 influenza virus crossed the U.S. border and raised concerns that it might cause a full-scale epidemic in the fall. The Food and Drug Administration worked with other Health and Human Services agencies and vaccine manufacturers to quickly develop, license and distribute a vaccine to protect the public from this particularly virulent strain of the flu.
› Verified 4 days ago